Jasper Therapeutics, Inc. (JSPR) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$1.3
Day's range
$1.39

Jasper Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VELAN CAPITAL INVESTMENT MANAGEMENT LP 08/14/2026 2.67 M $1.12 M   0.00% 9.30%
ACORN CAPITAL ADVISORS, LLC 08/14/2026 1.44 M $604.03 K   1.89% 5.01%
KINGDON CAPITAL MANAGEMENT, L.L.C. 08/14/2026 1.35 M $569.24 K   0.00% 4.71%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 1.17 M $493.42 K   -0.05% 4.08%
ROCK SPRINGS CAPITAL MANAGEMENT LP 08/14/2026 1.10 M $463.41 K   0.00% 3.84%
CARLYLE GROUP INC. 08/07/2026 1.07 M $448.87 K   0.00% 3.72%
GSA CAPITAL PARTNERS LLP 08/06/2026 534.70 K $225.00 K   2,701.81% 1.86%
MILLENNIUM MANAGEMENT LLC 08/14/2026 486.93 K $205.00 K   -69.90% 1.70%
LION POINT CAPITAL, LP 08/14/2026 465.00 K $195.77 K   0.00% 1.62%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 263.81 K $111.09 K   -16.96% 0.92%
RENAISSANCE TECHNOLOGIES LLC 08/13/2026 237.90 K $100.16 K   34.03% 0.83%
CITADEL ADVISORS LLC 09/02/2026 206.00 K $86.73 K   346.85% 0.72%
BLACKROCK, INC. 08/07/2026 169.63 K $71.41 K   -29.92% 0.59%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 149.94 K $63.13 K   0.00% 0.52%
ADAR1 CAPITAL MANAGEMENT, LLC 08/14/2026 140.00 K $58.94 K   0.00% 0.49%
QUARRY LP 08/14/2026 131.53 K $55.37 K   0.00% 0.46%
JANE STREET GROUP, LLC 08/14/2026 101.74 K $42.83 K   375.10% 0.35%
JANE STREET GROUP, LLC 08/14/2026 83.60 K $35.20 K   5.69% 0.29%
UBS GROUP AG 08/13/2026 58.76 K $24.74 K   -27.56% 0.20%
JAIN GLOBAL LLC 08/14/2026 51.19 K $21.55 K   184.01% 0.18%
ADVISOR GROUP HOLDINGS, INC. 08/14/2026 45.85 K $19.30 K   12.24% 0.16%
STATE STREET CORP 08/07/2026 44.70 K $18.82 K   0.00% 0.16%
NORTHERN TRUST CORP 08/13/2026 41.88 K $17.63 K   21.13% 0.15%
DIKER MANAGEMENT LLC 08/14/2026 35.00 K $15.00 K   0.00% 0.12%
QUBE RESEARCH & TECHNOLOGIES LTD 08/14/2026 33.72 K $14.20 K   100.00% 0.12%
XTX TOPCO LTD 08/14/2026 33.41 K $14.06 K   -15.28% 0.12%
SIMPLEX TRADING, LLC 08/12/2026 28.59 K $12.04 K   -2.33% 0.10%
IKARIAN CAPITAL, LLC 08/14/2026 24.09 K $10.14 K   0.00% 0.08%
CITADEL ADVISORS LLC 09/02/2026 22.40 K $9.43 K   -20.00% 0.08%
GROUP ONE TRADING, L.P. 08/14/2026 19.93 K $8.39 K   2,151.98% 0.07%
REHMANN CAPITAL ADVISORY GROUP 08/20/2026 15.30 K $6.44 K   0.00% 0.05%
SEQUENT PLANNING LLC 08/14/2026 14.90 K $6.27 K   0.00% 0.05%
BANK OF AMERICA CORP /DE/ 08/14/2026 14.19 K $5.98 K   -95.16% 0.05%
IEQ CAPITAL, LLC 08/11/2026 13.54 K $5.70 K   -73.68% 0.05%
ENGINEERS GATE MANAGER LP 08/14/2026 12.99 K $5.47 K   -50.29% 0.05%
LPL FINANCIAL LLC 08/07/2026 12.25 K $5.16 K   0.00% 0.04%
SG AMERICAS SECURITIES, LLC 08/07/2026 10.56 K $4.00 K   100.00% 0.04%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 10.30 K $4.33 K   100.00% 0.04%
TOWER RESEARCH CAPITAL LLC (TRC) 08/11/2026 9.34 K $3.93 K   48.07% 0.03%
MORGAN STANLEY 08/13/2026 1.72 K $726   -99.87% 0.01%
SRS CAPITAL ADVISORS, INC. 08/10/2026 573 $241   100.00% 0.00%
FEDERATED HERMES, INC. 08/12/2026 189 $80   -95.11% 0.00%
NATIONAL BANK OF CANADA /FI/ 08/10/2026 160 $63   0.00% 0.00%
BNP PARIBAS ARBITRAGE, SNC 08/13/2026 141 $59   0.00% 0.00%
SBI SECURITIES CO., LTD. 07/23/2026 64 $27   -1.54% 0.00%
JONES FINANCIAL COMPANIES LLLP 08/14/2026 50 $17   0.00% 0.00%
JPMORGAN CHASE & CO 08/12/2026 9 $4   0.00% 0.00%
US BANCORP \DE\ 08/12/2026 0 $0   -100.00% 0.00%
WELLS FARGO & COMPANY/MN 08/14/2026 0 $0   -100.00% 0.00%
DIMENSIONAL FUND ADVISORS LP 08/11/2026 0 $0   -100.00% 0.00%

Jasper Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 69 institutional investors and hedge funds held shares of Jasper Therapeutics Inc. The most heavily invested institutionals were:

Velan Capital Investment Management LP: 2.67 M

ACORN CAPITAL ADVISORS, LLC: 1.44 M

KINGDON CAPITAL MANAGEMENT, L.L.C.: 1.35 M

VANGUARD CAPITAL MANAGEMENT LLC: 1.17 M

Rock Springs Capital Management LP: 1.1 M

Carlyle Group Inc.: 1.07 M

41.82% of Jasper Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 21.28 M shares in the last 24 months. This purchase volume represents approximately $27.88 M in transactions.